Aptose Biosciences Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aptose Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Aptose Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was -$13K, a 102% decline year-over-year.
  • Aptose Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.41M, a 65.5% decline year-over-year.
  • Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.65M, a 29.8% decline from 2022.
  • Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.21M, a 59.8% decline from 2021.
  • Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.9M, a 39.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.65M -$1.55M -29.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $5.21M -$7.74M -59.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $12.9M -$8.49M -39.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $21.4M +$19.1M +834% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $2.3M -$1.98M -46.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 $4.28M +$4.22M +6910% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $61K Jan 1, 2017 Dec 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.